Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly

Andrea Ziblat1, Ximena Lucía Raffo Iraolagoitia1, Sol Yanel Nuñez1

  • 1Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.

Insights

Natural killer (NK) cells in kidney cancer (ccRCC) show dysfunction. Researchers identified specific cell markers on peripheral blood NK cells that can distinguish ccRCC patients from healthy donors, suggesting new biomarkers and immunotherapy targets.

Area of Science:

  • Immunology
  • Oncology
  • Renal Cell Carcinoma Research

Background:

  • Natural killer (NK) cells are crucial immune cells that infiltrate clear cell renal cell carcinomas (ccRCC).
  • Despite infiltration, NK cells often become dysfunctional within the tumor microenvironment, hindering anti-tumor immunity.
  • Understanding NK cell phenotypic changes in ccRCC is vital for identifying new biomarkers and therapeutic targets.

Purpose of the Study:

  • To perform a detailed phenotypic analysis of peripheral blood NK cells (PBNK) and tumor-infiltrating NK cells (TINK) in ccRCC patients.
  • To identify potential biomarkers and immunotherapy targets by analyzing NK cell surface marker expression.
  • To correlate NK cell marker expression with ccRCC patient status and NK cell infiltration.

Main Methods:

  • Phenotypic analysis of PBNK and TINK from ccRCC patients and healthy donors (HD) using flow cytometry.
  • Analysis of The Cancer Genome Atlas (TCGA) data to assess gene expression in ccRCC tumors.
  • Statistical analysis, including z-score calculations, to identify distinguishing markers.

Main Results:

  • PBNK from ccRCC patients showed increased expression of CD25, CD69, CD62L, DNAM-1, CD48, CD45, MHC-I, and PD-1, with reduced NKG2D and increased CD85j+
  • TINK exhibited higher activation markers and tissue residency features but decreased expression of activating receptors (DNAM-1, NKp30, NKp46, NKp80, CD16), indicating an inhibitory phenotype.
  • TCGA analysis revealed significant overexpression of CD48, CD45, CD85j, and PD-1 in ccRCC, associated with NK cell infiltration signatures. These markers, particularly on PBNK, differentiated ccRCC patients from HD.

Conclusions:

  • Specific phenotypic markers on NK cells, including CD48, CD45, CD85j, and PD-1, are altered in ccRCC patients.
  • These markers, especially when evaluated on PBNK, show potential as novel biomarkers for distinguishing ccRCC patients from healthy individuals.
  • The identified markers represent promising targets for developing novel immunotherapies to enhance anti-tumor responses in ccRCC.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
7.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K